AUD/USD: Australia’s lagging vaccine rollout highlights aussie's downside risks – Credit Suisse
|Economists at Credit Suisse highlight the disappointing pace of Australia’s COVID-19 vaccine rollout as reinforcing the potential AUD-downside risks within the medium-term 0.7415-0.7800 range.
Lockdowns are currently more of a risk than an immediate driver
“COVID-19 cases in Australia remain controlled, and markets remain relatively constructive on Australia’s growth outlook. The April IMF report upgraded Australian growth expectations to 4.5% in 2021, a full percentage point above their Jan estimate.”
“For now, we think that vaccine delays are more likely to cap AUD upside rather than trigger an AUD downtrend. Given the government’s sensitivity to COVID-19 spikes, however, we think the balance of risks could deteriorate quickly if infection numbers were to rise.”
“The currently stable status quo keeps us thinking that targeting a range of between 0.7415 and 0.7800 in AUD7USD is appropriate. Lingering faith in the reflation trade leaves us still expecting AUD outperformance against the funding currencies.”
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.